Fig. 3
From: Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker
The genetic alterations of RNF43. A Summary of RNF43 structural variant, mutations, and copy-number alterations. B Summary of RNF43 alterations in TCGA pan-cancer cohort. C The putative copy-number alterations of RNF43 in pan-cancer. D The mutation number, type, and site of the RNF43 genetic alterations. E The cooccurrence of gene alteration in RNF43 altered group and unaltered group. F Correlations of RNF43 alternations with PFS in TCGA pan-cancer cohort. G Correlations of RNF43 alternations with DSS in TCGA pan-cancer cohort. H Correlations of RNF43 alternations with OS in TCGA pan-cancer cohort. I Correlations of RNF43 alternations with mutation count in TCGA pan-cancer cohort. J Correlations of RNF43 alternations with TMB in TMB and immunotherapy cohort. K Correlations of RNF43 alternations with mutation count in TMB and immunotherapy cohort. L Correlations of RNF43 alternations with TMB in TMB and immunotherapy cohort